Trim 15-20% on $160 breakout confirmation with volume >2.5M, retain 80-85% core; stop at $150-151, hard exit at $145.83 weekly close
Underweight rating with 15-20% conditional trim applies directional caution given price extension above upper Bollinger band ($157.91) on weak volume (1.94M vs 3.9M base), forward EPS $7.26 requiring 60% step-up from TTM $4.57 with 50-60% historical disappointment probability, and 10Y at 2007 highs creating $5.7B short-term debt refinancing risk. However, the trim is materially smaller than Research Manager's 25-40% based on binding 9/21 and 9/24 EMR reflections that explicitly documented moderating setups (intact rising 200 SMA at $143, weeks-not-days catalyst, defended structural anchors) should reduce trim ceilings toward Hold or 10-15%. Tighter stop at $150-151 sits below 50 SMA at $152.60 and Bollinger midline at $151.18; $145.83 remains hard exit on weekly close. Catalyst calendar: Q4 FY26 print (early November 2026) primary validation point, with Late October FOMC and CPI forming macro cluster. Retain 80-85% core to preserve participation if breakout confirms above $163 with volume; reload on confirmed close above $163 with rising volume.
| Position | Action |
|---|---|
| Confirmed push above $160 with volume >2.5M and follow-through close | Trim 15-20% of EMR position, retaining 80-85% as core |
| $160 fails on weak volume | Trim 25-30% (failure of breakout scenario) |
| Weekly close below $145.83 | Full exit (trend failure, not noise) |
EMR is a high-quality cash-flow compounder in a confirmed technical uptrend, with restructuring charges rolling off, software-driven margin expansion, and secular demand tailwinds from AI data-center power build-out that make the current valuation attractive relative to cracking peer multiples.
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 60.99 | bullish |
| MACD | 0.51 | bullish |
| MACD Signal | -0.41 | bullish |
| MACD Histogram | +0.92 | bullish |
| 10 EMA | $153.27 | bullish |
| 50 SMA | $152.60 | bullish |
| 200 SMA | $143.26 | bullish |
| VWMA | $150.87 | bullish |
| ATR | $3.67 | neutral |
| Bollinger Middle | $151.18 | neutral |
| Bollinger Upper | $157.91 | bullish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: $160 fails on weak volume
Then: Trim 25-30%
EV: +10:1 risk/reward to August high at $163.17 (~$165+ target) · concedes: Today's close at $158.23 sits above the upper Bollinger band of $157.91, and printed volume of 1.94M is lighter than the 3.9M reversal sessions earlier in the base — a fair technical concern; Volume confirmation may come on day 2, not day 1; Bear correctly notes TTM P/E of 34.6× is elevated — but analyst argues this is misleading due to restructuring charges rolling off; Eaton's margin compression warning is a fair concern for peer group, though analyst contends EMR's margin trajectory is in opposite direction
EMR is priced for perfection at 34.6× TTM P/E and 1.80× PEG with negative tangible book and rising rate headwinds, offering unfavorable asymmetry where the bull case yields ~3% upside but downside scenarios span 10–37% drawdowns if consensus EPS of $7.26 doesn't materialize.
EV: -$20 to -$25 (25% downside from $158 to $120-133 range) · concedes: Technical setup is constructive—MACD flipped positive, 50/200 SMA alignment is bullish; Restructuring charges are real and do roll off, providing some EPS denominator improvement; Dividend is committed and cannot be cut, providing floor on capital return; If Q4 FY26 prints $1.80+ and guides FY27 to $7.50+, the bull case earns its multiple; A pullback to $148–$150 would offer better risk/reward if narrative remains intact
→ vs conservative: TTM P/E of 34.6 is distorted by restructuring charges and FY25 transition year; forward P/E of 21.8 is the relevant metric showing EMR fairly valued vs. peers at 18-25x
→ vs conservative: Volume on breakout day was 1.94 million shares on a declining market, which is positive relative strength not distribution; capitulation days at 3.9 million shares marked accumulation
→ vs conservative: Bollinger band argument applied backwards; $0.32 above upper band in confirmed uptrend with rising RSI 55-70 and bullish MACD crossover is continuation, not exhaustion
→ vs conservative: Historical 50-60% disappointment probability is irrelevant when Q3 shows revenue re-acceleration, highest FCF in six quarters, and rolling-off restructuring charges
→ vs conservative: Macro headwinds (high rates) actually favor EMR as capex-intensive automation gets more valuable in tight labor, energy transition, and AI data-center environments
→ vs neutral: Single session below-average volume on a tape-wide risk-off day tells nothing structural; structural accumulation pattern with VWAP $150.87 shows quiet accumulation resolving into markup
| Bollinger Lower | $144.46 | neutral |
Support: 157.91 · 153.27 · 152.6 · 151.18 · 144.46 | Resistance: 159.87 · 163.17 · 165.79
Multi-month structure is bullish with price closing above all major moving averages and the upper Bollinger Band ($157.91), supported by a golden cross (50 SMA > 200 SMA) and positive MACD histogram. The 5-day reversal from the 9/16 low of $145.83 represents a clean higher-low pattern completing a flag/consolidation beneath the August high. Near-term concerns include price being stretched above the upper band on below-average volume (1.94M vs. 2-3M+ base days), suggesting a pullback to retest $152-$153 would be a healthier entry rather than chasing at $158.23. Key invalidation below $151.18 (Bollinger middle) would shift the near-term bias.
Market Cap
$88.26 B
Diluted EPS (TTM)
$4.57
Forward EPS (Consensus)
$7.26
P/E (TTM)
34.6×
Forward P/E
21.8×
PEG Ratio
1.80
Price / Book
4.33×
Dividend Yield
1.42%
Beta
1.23
52-Week Range
$122.64 – $166.35
50-Day MA
$152.42
200-Day MA
$143.98
Revenue (TTM)
$18.64 B
Gross Profit
$9.91 B
Gross Margin
53.2%
EBITDA
$6.06 B
Operating Margin
26.9%
Net Income (TTM)
$2.576 B
Net Profit Margin
13.8%
ROE
12.8%
ROA
6.9%
Cash & Equivalents
$2.18 B
Total Debt
$13.26 B
Net Debt
$10.93 B
Stockholders' Equity
$20.38 B
Goodwill & Intangibles
$26.81 B
Net Tangible Assets
($6.43 B)
Current Ratio
0.90
Working Capital
($1.12 B)
Total Debt / Equity
65%
Net Debt / EBITDA
1.8×
Interest Coverage
9×
Free Cash Flow (TTM)
$3.71 B
FCF Yield
~3.0%
Q3 FY26 FCF
$1.32 B
Annual Buyback Run Rate
~$1.2-1.5 B/yr
Revenue FY2025
$18.02 B
Revenue FY2024
$17.49 B
Net Income FY2025
$2.29 B
Diluted EPS FY2025
$4.04
Restructuring Charges FY2025
$350 M
Q3 FY26 Restructuring Charges
$109 M
Strengths
Concerns
Emerson Electric has successfully repositioned itself into a higher-margin, automation-focused business following the May 2024 mega-deal that divested its Safety & Industrial Sensing segment for ~$8.2 B and subsequent acquisitions including AspenTech, Minsait ACS, and Afag. The company now operates through Intelligent Devices and Final Control segments, serving energy, chemical, power, and life sciences end markets. Financial performance shows strong operational improvement: Q3 FY26 revenue accelerated to +7.0% YoY, operating margins are best-in-class at 26.9%, and FCF reached $1.32 B (highest in 6 quarters), while restructuring charges are fading from ~$350 M annual run-rate. However, the balance sheet carries significant debt ($13.26 B) and negative tangible book value ($6.43 B), creating refinancing and impairment risks. The forward P/E of 21.8× is reasonable versus peers but the TTM P/E of 34.6× leaves little margin for disappointment. The stock is a "buy the dip, not chase" name — a pullback toward the 50-day MA (~$152) or 200-day MA (~$144) would offer better risk/reward.
Macro: Bond market sell-off drove 10Y Treasury to highest since 2007 and 30Y to highs since 2004, with mortgage rates approaching 7.5%; markets actively pricing another Fed rate hike (Polymarket 90% probability) with 97% probability of no cuts in 2026. US recession odds remain low at 10% (Polymarket). Trump–Xi détente late-week eased risk-off. Oil eased as JPMorgan abandoned Iran-war forecast; binary geopolitical risk unresolved. Hard-landing narrative not priced.